BCL2 and stroke disorder: Intranasal administration of apelin-13 significantly suppressed the caspase-3 activation and increased the survival gene Bcl-2 after stroke, providing an antiapoptotic mechanism of apelin-13 in the ischemic brain (Tang et al., 2007; Zeng et al., 2010; Yang et al., 2014).